Australia · Delayed Price · Currency is AUD Anagenics Statistics
Total Valuation
Anagenics has a market cap or net worth of AUD 5.91 million. The enterprise value is 5.37 million.
| Market Cap | 5.91M |
| Enterprise Value | 5.37M |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Anagenics has 985.45 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 985.45M |
| Shares Outstanding | 985.45M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | -36.58% |
| Owned by Insiders (%) | 25.23% |
| Owned by Institutions (%) | n/a |
| Float | 464.44M |
Valuation Ratios
The trailing PE ratio is 15.04.
| PE Ratio | 15.04 |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.40 |
| EV / Sales | 1.04 |
| EV / EBITDA | 9.75 |
| EV / EBIT | 14.74 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.27 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | -0.03 |
| Interest Coverage | 5.27 |
Financial Efficiency
Return on equity (ROE) is 10.19% and return on invested capital (ROIC) is 6.57%.
| Return on Equity (ROE) | 10.19% |
| Return on Assets (ROA) | 5.15% |
| Return on Invested Capital (ROIC) | 6.57% |
| Return on Capital Employed (ROCE) | 8.62% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.17 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks. The beta is 0.43, so Anagenics's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 43.95 |
| Average Volume (20 Days) | 584,957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anagenics had revenue of AUD 5.16 million and earned 308,472 in profits. Earnings per share was 0.00.
| Revenue | 5.16M |
| Gross Profit | 3.00M |
| Operating Income | 364,261 |
| Pretax Income | 308,472 |
| Net Income | 308,472 |
| EBITDA | 550,497 |
| EBIT | 364,261 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 577,429 in cash and 33,192 in debt, with a net cash position of 544,237 or 0.00 per share.
| Cash & Cash Equivalents | 577,429 |
| Total Debt | 33,192 |
| Net Cash | 544,237 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.23M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.22M |
Cash Flow
In the last 12 months, operating cash flow was -1.07 million and capital expenditures -24,952, giving a free cash flow of -1.09 million.
| Operating Cash Flow | -1.07M |
| Capital Expenditures | -24,952 |
| Depreciation & Amortization | 205,139 |
| Net Borrowing | 439,789 |
| Free Cash Flow | -1.09M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 58.15%, with operating and profit margins of 7.06% and 5.98%.
| Gross Margin | 58.15% |
| Operating Margin | 7.06% |
| Pretax Margin | 5.98% |
| Profit Margin | 5.98% |
| EBITDA Margin | 10.67% |
| EBIT Margin | 7.06% |
| FCF Margin | n/a |
Dividends & Yields
Anagenics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | 5.22% |
| FCF Yield | -18.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 27, 2017. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 27, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Anagenics has an Altman Z-Score of -12.42 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.42 |
| Piotroski F-Score | 5 |